| Literature DB >> 27438474 |
Cristian A Alvarez Rojas1, Jean-Pierre Scheerlinck1, Brendan R E Ansell2, Ross S Hall2, Robin B Gasser2, Aaron R Jex2,3.
Abstract
Fasciola hepatica is a parasitic trematode that infects a wide range of mammalian hosts, including livestock and humans, in temperate and tropical regions globally. This trematode causes the disease fascioliasis, which consists of an acute phase (≤ 12 weeks) during which juvenile parasites migrate through the host liver tissues, and a chronic phase (> 12 weeks) following the establishment of adult parasites in the liver bile ducts. Few studies have explored the progression of the host response over the course of Fasciola infection in the same animals. In this study, we characterized transcriptomic changes in peripheral blood mononuclear cells (PBMCs) collected from sheep at three time points over the first eight weeks of infection relative to uninfected controls. In total, 183 and 76 genes were found to be differentially transcribed at two and eight weeks post-infection respectively. Functional and pathway analysis of differentially transcribed genes revealed changes related to T-cell activation that may underpin a Th2-biased immune response against this parasite. This first insight into the dynamics of host responses during the early stages of infection improves the understanding of the pathogenesis of acute fascioliasis, informs vaccine development and presents a set of PBMC markers with diagnostic potential.Entities:
Mesh:
Year: 2016 PMID: 27438474 PMCID: PMC4954650 DOI: 10.1371/journal.pone.0159194
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Biological processes terms (Gene ontology) overrepresented for UP- and DOWN-regulated genes in ovine peripheral blood mononuclear cells (PBMCs) after 2 and 8 weeks post infection with Fasciola hepatica.
| lipoxygenase pathway | 42.7 | 2.38E-02 | GPX4, LTC4S, ALOX5AP, ALOX5 | |
| positive regulation of alpha-beta T cell proliferation | 36.52 | 2.79E-03 | LGALS9, HLA-A, EBI3 | ZAP70, CD28 |
| positive regulation of T cell activation | 6.67 | 2.71E-02 | LGALS9, HLA-A, AIF1, HLA-DRB1, CCL2, TGFB1, EBI3, PYCARD | ZAP70, CD28 |
| regulation of interferon-gamma production | 10.44 | 4.97E-02 | LGALS9, HLA-A, HLA-DRB1, EBI3, PYCARD, PGLYRP1 | CCR7 |
| humoral immune response | 8.58 | 7.44E-04 | HLA-A, C1QB, FCN2, BST2, HLA-DRB1, CCL2, C4BPA, EBI3, C1QC, ANG | CD28 |
| response to lipopolysaccharide | 6.23 | 6.38E-04 | PF4V1, LGALS9, MGST1, HCK, CD300LB, LTC4S,S100A8, CCL2, TGFB1, PYCARD, NR1H3, CCR7, CEBPE | CD27 |
| leukocyte migration | 5.8 | 3.24E-02 | PF4V1, S100A9, S100A12, HCK, CCL23, S100A8, CCL2 | PLCG1, L1CAM, ZAP70, CCR7 |
| positive regulation of cytokine production | 4.71 | 4.04E-02 | CLEC6A, PRG3, LGALS9, HLA-A, NFAM1, CCL2,TGFB1, EBI3, PYCARD, CLEC4E, SPTBN1 | CD28, CCR7 |
| innate immune response | 4.01 | 2.86E-07 | PLCG1, CLEC6A, LGALS9, HLA-A, C1QB, FCN2, S100A9, S100A12, TYROBP, BST2, HCK, CD300LB, CCL23, AIF1, S100A8, DUSP6, HLA-DRB1, CCL2, TGFB1, C4BPA, PADI4, PYCARD, CLEC4E, C1QC, PGLYRP1 | RNF125, SPTBN1, ZAP70, CD28, DUSP7 |
| lipoxin metabolic process | > 100 | 1.18E-02 | ALOX5AP, ALOX5, ALOX15 | |
| leukotriene metabolic process | 49.37 | 5.78E-04 | PRG3, ALOX5AP, ALOX5, ALOX15 | CYP4F3 |
| negative regulation of immune response | 15.74 | 2.05E-02 | LGALS9, LILRB2, C4BPA, ALOX15, DUSP10 | IRG1 |
Final number of differentially transcribed genes (DTGs) in ovine peripheral blood mononuclear cells (PBMCs) at 2 and 8 Weeks post infection (WPI) after infection with Fasciola hepatica.
| Condition | 2 WPI | 8 WPI |
|---|---|---|
| UP-regulated | 135 | 63 |
| DOWN-regulated | 48 | 13 |
| Total | 183 | 76 |
Molecular function terms (Gene ontology) overrepresented for UP- and DOWN-regulated genes from ovine peripheral blood mononuclear cells (PBMCs) after 2 weeks post infection with Fasciola hepatica.
| GO molecular function | Fold Enrichment | P value | UP | DOWN |
|---|---|---|---|---|
| arachidonic acid binding | 69.38 | 3.40E-02 | S100A9, S100A8, ALOX5AP | |
| RAGE receptor binding | 50.46 | 3.95E-03 | S100A9, S100A12, S100A8, S100A4 | |
| cytokine receptor binding | 5.53 | 1.63E-02 | PF4V1, SMAD2, LRG1, CCL23, CCL2, TGFB1, EBI3, PYCARD, TFF2, ECM1 | PLCG1 |